Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
Titel:
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
Auteur:
Crowell, Trevor A Colby, Donn J Pinyakorn, Suteeraporn Sacdalan, Carlo Pagliuzza, Amélie Intasan, Jintana Benjapornpong, Khunthalee Tangnaree, Kamonkan Chomchey, Nitiya Kroon, Eugène de Souza, Mark S Tovanabutra, Sodsai Rolland, Morgane Eller, Michael A Paquin-Proulx, Dominic Bolton, Diane L Tokarev, Andrey Thomas, Rasmi Takata, Hiroshi Trautmann, Lydie Krebs, Shelly J Modjarrad, Kayvon McDermott, Adrian B Bailer, Robert T Doria-Rose, Nicole Patel, Bijal Gorelick, Robert J Fullmer, Brandie A Schuetz, Alexandra Grandin, Pornsuk V O'Connell, Robert J Ledgerwood, Julie E Graham, Barney S Tressler, Randall Mascola, John R Chomont, Nicolas Michael, Nelson L Robb, Merlin L Phanuphak, Nittaya Ananworanich, Jintanat